Extendicare Inc. (TSX:EXE)
30.34
+0.25 (0.83%)
Nov 13, 2026, 4:00 PM EST
Extendicare Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Extendicare stock has a consensus rating of "Strong Buy" and an average price target of $39.00. The average 1-year stock price forecast is 28.54% higher than the current stock price, while the lowest is $31.50 (+3.82%) and the highest is $44.00 (+45.02%).
Price Target: $39.00 (+28.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Extendicare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $39.00 | Buy | Maintains | $39.00 | +28.54% | Nov 11, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $38.00 | Buy | Maintains | $38.00 | +25.25% | Nov 10, 2026 |
Unknown Analyst Desjardins No rating | Desjardins | Buy Maintains $39.00 → $39.50 | Buy | Maintains | $39.00 → $39.50 | +30.19% | Nov 10, 2026 |
| CIBC | CIBC | Buy Reiterates $40.00 | Buy | Reiterates | $40.00 | +31.84% | Nov 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $44.00 | Buy | Maintains | $44.00 | +45.02% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
2.34B
from 1.66B
Increased by 40.92%
Revenue Next Year
2.56B
from 2.34B
Increased by 9.50%
EPS This Year
1.48
from 1.11
Increased by 33.33%
EPS Next Year
1.64
from 1.48
Increased by 10.29%
EPS based on non-GAAP adjusted numbers. Financial currency is CAD.